Impact of controlling atrial fibrillation on outcomes relevant to the patient: focus on dronedarone

Atrial fibrillation (AF) is a substantial cause of mortality and morbidity in the Western world. It is a massive burden on health care systems, and its prevalence is expected to double over the next 20 years. Trials evaluating antiarrhythmic drugs or catheter ablation have focused on recurrence of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chahal, C Anwar A, Ali, Omer, Hunter, Ross J, Schilling, Richard J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3557702/
https://www.ncbi.nlm.nih.gov/pubmed/23378791
http://dx.doi.org/10.2147/PROM.S16678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3557702/
https://www.ncbi.nlm.nih.gov/pubmed/23378791
http://dx.doi.org/10.2147/PROM.S16678

Ejemplares similares